Boston Scientific

Open: 50.9 Close: 52.03 Change: 1.13

Our AI found 16 flaws in Boston Scientific Company Inc.

Are looking for the most relevant information about Boston Scientific? Investor spend a lot of time searching for information to make investment decisions in Boston Scientific. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Boston Scientific are: Boston, Scientific, quarter, report, share, cent, Q1, and the most common words in the summary are: boston, scientific, stock, news, market, net, income, . One of the sentences in the summary was: Medical device maker increased its full-year revenue guidance.. Other searches related …

Concept Map

Semantic Network

Stock Summary

Boston Scientific develops, manufactures, and markets medical devices for use in various interventional medical specialties. It operates through MedSurg and Cardiovascular segments. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat.

Today's Summary

Better-than-expected Q1 2023 report from Boston Scientific sent its shares 3% higher in the pre-market Wednesday. Medical device maker increased its full-year revenue guidance.

Today's News

Boston Scientific Corp. stock outperforms market despite losses on the day - marketwatch. boston scientific corp. stock out outperforms. Better-than-expected Q1 2023 report from Boston Scientific sent its shares 3% higher in the pre-market Wednesday. Medical device maker increased its full-year revenue guidance exceeding forecasts. Boston Scientific Corp. expects its per-share earnings to range from 48 cents to 50 cents for the current quarter ending in June. Boston Scientific further advanced diversity, equity and inclusion in its workplace. Medical device maker Boston Scientific has been looking to buy the California-based company Shockwave. Shockwave shares rose 6.9%, while Boston Scientific shares fell 1.9% in morning trade. Boston Scientific expects its per-share earnings to range from 48 cents to 50. Boston Scientific expects its per-share earnings to range from 48 cents to 50 cents for the current quarter ending in June. Boston Scientific shares have risen 10% since the beginning of the year, while the S&Ps 500 index has climbed 6%. Boston Scientific: Q1 Earnings Snapshot. The company reported GAAP net income attributable to Boston Scientific common stockholders of $300 million or $0.21 per share (EPS) Im pleased with our excellent results this quarter, said Mike Mahoney. For the current quarter ending in June, Boston Scientific expects its per-share earnings to range from 48 cents. Boston Scientific generated net sales of $3.389 billion during the first quarter of 2023, growing 12.0 percent on a reported basis, 14.9 percent on an operational 1 basis and 14.0% on an organic 2 basis. The company reported GAAP net income attributable to Boston Scientific common stockholders of $300 million or $0.21 per share. Boston Scientific has reported a 185.45% rise in net income to $314m in the first quarter (Q1) of 2023. Boston Scientific chairman and CEO Mike Mahoney said: “Im pleased with our excellent results this quarter which highlight our teams strong performance. Boston Scientific reported better-than-expected first-quarter growth on Tuesday, but BSX stock yo-yoed on the results. Trefis estimates Boston Scientifics Q1 2023 revenues to be around $3.2 billion. Our interactive dashboard analysis of the Boston Scientific Earnings Preview has additional details.

Stock Profile

"Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through MedSurg and Cardiovascular segments. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, that uses in the treatment of coronary artery disease and aortic valve conditions. Further, it provides stents, balloon catheters, guidewires, atherectomy, and thrombectomy systems to treat arterial and venous diseases; and peripheral embolization devices, radioactive microspheres, cryotherapy ablation systems, and micro and drainage catheters to treat cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts."

Keywords

This document will help you to evaluate Boston Scientific without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Boston Scientific are: Boston, Scientific, quarter, report, share, cent, Q1, and the most common words in the summary are: boston, scientific, stock, news, market, net, income, . One of the sentences in the summary was: Medical device maker increased its full-year revenue guidance.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #boston #scientific #stock #news #market #net #income.